These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364 [TBL] [Abstract][Full Text] [Related]
4. Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond. Günday Türeli N; Türeli AE; Schneider M Int J Pharm; 2016 Sep; 511(2):994-1001. PubMed ID: 27520732 [TBL] [Abstract][Full Text] [Related]
5. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies. Khan AM; Ahmad FJ; Panda AK; Talegaonkar S Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254 [TBL] [Abstract][Full Text] [Related]
6. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles. Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381 [TBL] [Abstract][Full Text] [Related]
7. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa. Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589 [TBL] [Abstract][Full Text] [Related]
8. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Dillen K; Vandervoort J; Van den Mooter G; Verheyden L; Ludwig A Int J Pharm; 2004 May; 275(1-2):171-87. PubMed ID: 15081148 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Dillen K; Vandervoort J; Van den Mooter G; Ludwig A Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538 [TBL] [Abstract][Full Text] [Related]
10. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization. Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467 [TBL] [Abstract][Full Text] [Related]
11. Polymer assisted entrapment of netilmicin in PLGA nanoparticles for sustained antibacterial activity. Kolate A; Kore G; Lesimple P; Baradia D; Patil S; Hanrahan JW; Misra A J Microencapsul; 2015; 32(1):61-74. PubMed ID: 25238317 [TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity. Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236 [TBL] [Abstract][Full Text] [Related]
13. Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into Wan F; Bohr SS; Kłodzińska SN; Jumaa H; Huang Z; Nylander T; Thygesen MB; Sørensen KK; Jensen KJ; Sternberg C; Hatzakis N; Mørck Nielsen H ACS Appl Mater Interfaces; 2020 Jan; 12(1):380-389. PubMed ID: 31804792 [TBL] [Abstract][Full Text] [Related]
14. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release. Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase). Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442 [TBL] [Abstract][Full Text] [Related]
16. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis. Patel KK; Tripathi M; Pandey N; Agrawal AK; Gade S; Anjum MM; Tilak R; Singh S Int J Pharm; 2019 May; 563():30-42. PubMed ID: 30926526 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
19. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
20. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles. Bozdag S; Dillen K; Vandervoort J; Ludwig A J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]